BiotechTube
Home/STRM.BIO/Michael Luther, Ph.D., MBA
ML

Michael Luther, Ph.D., MBA

Chief Executive Officer

STRM.BIO

Therapeutic Areas

Rare Hematological DiseasesOncology

STRM.BIO Pipeline

DrugIndicationPhase
MV Platform for Rare DiseaseFanconi anemiaPreclinical
MV Platform for Cell TherapyIn vivo CAR-T therapiesPreclinical

Leadership Team at STRM.BIO

RH
Robert Hughes
Chief Financial Officer
LG
Laura Goldberg, M.D., Ph.D.
Vice President of Research
View full STRM.BIO profile